Tuning the potency and therapeutic window of ImmTAC molecules by affinity modulation

Ian B. Robertson(Immunocore (United Kingdom)), Peter Kirk(Immunocore (United Kingdom))
bioRxiv (Cold Spring Harbor Laboratory)
November 4, 2022
Cited by 0


Related Papers